Author Correction: Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes

Affiliations

• ¹ Unit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium. sophia.maschalidi@irc.vib-ugent.be.
• ² Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. sophia.maschalidi@irc.vib-ugent.be.
• ³ Unit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium.
• ⁴ Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
• ⁵ Unit for Cellular and Molecular Pathophysiology, VIB Center for Inflammation Research, Ghent, Belgium.
• ⁶ Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
• ⁷ Laboratory of Neuro-Aging and Viro-Immunotherapy, Center for Neurosciences (C4N), Vrije Universiteit Brussel, Brussels, Belgium.
• ⁸ The Center for Cell Clearance, University of Virginia, Charlottesville, VA, USA.
• ⁹ Department of Microbiology, Immunology, and Cancer Biology, and the Center for Cell Clearance, University of Virginia, Charlottesville, VA, USA.
• ¹⁰ Unit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium. kodi@wustl.edu.
• ¹¹ Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. kodi@wustl.edu.
• ¹² The Center for Cell Clearance, University of Virginia, Charlottesville, VA, USA. kodi@wustl.edu.
• ¹³ Department of Microbiology, Immunology, and Cancer Biology, and the Center for Cell Clearance, University of Virginia, Charlottesville, VA, USA. kodi@wustl.edu.
• ¹⁴ Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. kodi@wustl.edu.